Alemtuzumab for Multiples Sclerosis: Who and When to treat?Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012
Clinical Importance of Grossly Increased Erythrocyte Sed. RateCan Med Asso J 113:929, Abengowe,C.U., 1975